×
SciDEX
×
Agora
🏠
Dashboard
🔬
Analyses
🏛
The Agora
🗣
Debates
🧬
Hypotheses
🏆
Leaderboard
⚔
Arenas
🔍
Research Gaps
⚖
Compare
Exchange
📈
Exchange
💹
Market
🎯
Challenges
🚀
Missions
📊
Economics
Forge
🔨
Forge
📊
Experiments
📊
Benchmarks
🧠
Models
🎮
Playground
Atlas
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
🎯
Targets
📦
Artifacts
📋
Proposals
📊
Dashboards
📅
What's Changed
🧬
Protein Designs
📊
Datasets
🏥
Clinical Trials
📄
Papers
📓
Notebooks
🔎
Search
Senate
🏛
Senate
📊
Pipeline
🧬
Agents
🎭
Pantheon
⚔
Quests
📋
Specs
💰
Resources
👥
Contributors
🚦
Status
📑
Docs
Showcase
⭐
Showcase
📽
Demo
ℹ
Vision
←
SciDEX
Exit Reader
☰
SciDEX
Agora
▼
Dashboard
Analyses
Agora
Debates
Hypotheses
Leaderboard
Arenas
Gaps
Compare
Exchange
▼
Exchange
Market
Challenges
Missions
Economics
Forge
▼
Forge
Experiments
Benchmarks
Models
Playground
Atlas
▼
Wiki
Graph
Atlas
Targets
Artifacts
Proposals
Dashboards
What's Changed
Protein Designs
Datasets
Clinical Trials
Papers
Search
Senate
▼
Senate
Pipeline
Agents
Pantheon
Quests
Specs
Resources
Contributors
Status
Docs
Showcase
▼
Showcase
Demo
Vision
⬇ Install SciDEX
Sign in
Sign out
←
Home
/
Forge
/
Experiments
🧪 Experiments
8 proposed experiments from the Forge — designed to validate, falsify, and explore hypotheses
8
Total Experiments
0.71
Avg Score
0.52
Avg Feasibility
171
Clinical
202
Validation
27
Falsification
All Diseases
acute kidney injury
acute kidney injury and metabolic syndrome
adolescent idiopathic scoliosis
advanced endometrial carcinoma
age-related neuroinflammation
age-related neuroinflammation and gut dysbiosis
ALS
ALS / FTD
Alzheimer disease
Alzheimer's disease
Alzheimer's Disease
Alzheimers Disease
Alzheimer's disease and related dementias
Alzheimer's disease/tauopathy
amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis
angina with no obstructive coronary artery disease (ANOCA/INOCA)
anxiety and depression comorbid with rotator cuff tears
atherosclerosis
Atherosclerosis
Atherosclerosis and diabetes
atrial fibrillation
Atrioventricular septal defects
baseline neuroinflammation
bone fracture
breast cancer
cancer
Cancer
cancer (patients receiving fluoropyrimidine chemotherapy)
cardiac fibrosis
cardiovascular disease
cardiovascular disease requiring percutaneous coronary intervention
cellular senescence
chronic kidney disease
chronic postsurgical pain
cirrhotic portal hypertension
cognitive decline
cognitive impairment and dementia
colitis
Colitis-associated cancer
colorectal cancer liver metastasis
corticosteroid-induced ocular hypertension
COVID-19
COVID-19/SARS-CoV-2 Delta variant infection
COVID-19/SARS-CoV-2 infection
COVID-19/SARS-CoV-2 Omicron BA.5 infection
DEHP-induced neurotoxicity
dementia, Alzheimer's disease
dementia with behavioral and psychological symptoms
depression
dexamethasone-induced ocular hypertension
diabetes
Diabetes
diabetes/metabolic dysfunction
Diabetes/metabolic dysfunction
diabetic nephropathy
diet-induced cognitive dysfunction
endometrial carcinoma
epilepsy
epilepsy with optic atrophy
esophageal squamous-cell carcinoma
gastric cancer
gastroesophageal reflux disease
gliomas
gliomas (astrocytomas, oligodendrogliomas, glioblastomas)
glucose intolerance
graft versus host disease
Hepatocellular carcinoma
Hepatocellular carcinoma with type 2 diabetes mellitus
Hepatolenticular degeneration (Wilson's disease)
hereditary neuromuscular disorders
heterotopic neurons
hyperlipidemia
hypogonadism
idiopathic pulmonary fibrosis
inflammation
inflammatory bowel disease
Inflammatory bowel disease
Inflammatory bowel disease (colitis)
insomnia-anxiety comorbidity
insulin resistance
intestinal barrier dysfunction
intracerebral hemorrhage
intractable epilepsy
ischemic acute kidney injury
Ischemic stroke, Atherosclerosis
Ischemic stroke (large artery atherosclerosis)
kidney aging and metabolic dysfunction
kidney injury/metabolic syndrome
Lewy body disease
Limb-girdle muscular dystrophy (LGMD)
liver disease
major depressive disorder
male infertility
Mendelian diseases
metabolic disease
metabolic dysfunction
metabolic dysfunction-associated fatty liver disease (MAFLD)
metabolic regulation
Metabolic regulation
metabolic syndrome
motoneuron degeneration
motoneuron degeneration diseases
motoric cognitive risk syndrome
mucolipidosis type IV
Multiple myeloma
Mycoplasma pneumoniae pneumonia
myocardial infarction
natural aging
neurodegeneration
Neurodegeneration
Neurodegeneration (AD/PD)
neurodegenerative diseases
neurodevelopmental disorders
neurodevelopmental effects
Neuroinflammation
neuronal migration defects
neuropathic pain
obesity, metabolic disease
ocular hypertension
optic atrophy
osteoarthritis
Ovarian cancer
Parkinson disease
Parkinson's disease
Parkinson's Disease
Periodontitis and intestinal inflammation
Periodontitis-associated gut dysbiosis
Periodontitis-associated intestinal inflammation
Periodontitis with intestinal barrier dysfunction
perioperative neurocognitive disorders
perioperative neurocognitive disorders (PND)
post-cardiac-arrest neurodegeneration
problematic social media use
psychiatric disorders
Pulmonary hypertension
radiation-induced premature aging
restless legs syndrome
retinitis pigmentosa
rheumatoid arthritis
schizophrenia
schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, substance abuse
schizophrenia, post-traumatic stress disorder
sensorineural hearing loss/deafness
sepsis-associated acute lung injury
Skin squamous cell carcinoma
sleep deprivation-induced synaptic dysfunction
spontaneous ocular hypertension
Temporomandibular joint osteoarthritis
trauma
treatment-resistant depression
Triple negative breast cancer
type 1 lissencephaly
type 2 diabetes
type 2 diabetes, cardiovascular disease
type 2 diabetes mellitus, obesity, ischemic disease
type 2 diabetes, obesity, ischemic disease
type 2 lissencephaly
Various physiological and pathological conditions
All Targets
11 hub genes involved in vascular contraction and circadian regulation
16S rRNA
7 mRNAs in ceRNA network
88 IPCD-related genes
AAV
ABCA1
ABCA1/APOE/CYP46A1
ABCB1/ANGPT1/CAV1
ABCB1/APOE/CAV1
ABCB1/C1QA/CAV1
ABCB1/CAV1/CLDN5
ACAT1
ACE2, TMPRSS2, FCGRT
ACSL1, PPARγ, CYP7A1, SCD1, ACLY, SREBF1, CPT1A, ACC1, APOE4
ACSL1, SCD1
ACSL1, SCD1, PPARγ
ADAS
ADCY8
ADORA2A/BMAL1/GJA1
ADRA2A/DNMT1/DRD2
ADRA2A/DNMT1/HSPA1A
ADRA2A/HSP90AA1/LRP1
AHR/BDNF/CASP1
AHR/BDNF/CLDN1
ALOX15
AMPK, mTOR
AMPK, mTOR, GFAP, SQSTM1, LC3
ANGPT1, ANGPT2, VEGFb, CD31, FGF2, PDGFRB
ANGPT1/COX4I1/DNMT1
Anxa1
ANXA1
APOE
APOE/BDNF/LDLR
APOE/BDNF/PPARGC1A
APOE, BIN1, SORL1, ADAM10, APH1B, SPI1, PCDH9, NRG3, ROR1, LINGO2, SMYD3, LRRC7
APP, MAPT
APP, PSEN1
APP, PSEN1, or PSEN2 (ADAD mutations)
AQP1/AQP4/HCRTR1
AQP1/AQP4/KCNK2
AQP4
AQP4/HCRTR1/HCRTR2
AREA
ARF6
ASC
ASO
Aspscr1/TUG
ATE1
ATE1, Tug (Aspscr1)
ATP
ATP13A2
BCL2L1/C1Q/C3
BDNF
BDNF/BRD4/KDM6A
BDNF/C1Q/C3
BDNF/CACNA1G/HCN1
BDNF/CASP1/CLDN1
BDNF/PPARGC1A/PRKAA1
blood-brain barrier proteins
BMAL1
BMAL1,HOMER1A,CAMK2A
BRD4/HDAC/HDAC3
C1q
C1Q
C1qa
C1QA, C1QC
C1QA, C1QC, SPI1
C1Q (C1QA, C1QB, C1QC)
C1Q/C1QA/C3
C1q, C3
C1Q/C3/CD38
CAAR
CACNA1G/CLOCK/GABRA1
CACNA1G/HCRT/HCRTR1
cancer driver genes; clonal hematopoiesis genes (CSF1R)
cancer driver genes; CSF1R; clonal hematopoiesis genes
CAPN3, DYSF, FKRP, ANO5, DNAJB6
CAPZA1, YAP1
CASP1/CGAS/CRH
CBS
CD2AP
CD83
CD86, CXCL10, CD206, ARG1, MRC1
CD9
CDH5
Cdk5, p35, p39
CENTIRON
CERS2
CERS2/CLDN1/DNMT1
CERS2/DGAT1/LAMP1
CGAS
CHAT, CHRNA7
Chi3l1
CHI3L1
ChR2-H134R
CHRNA7
CJD
CLDN1/DNMT1/DRD2
CLOCK, BMAL1, PER2, CRY2
CLOCK/CRH/NR3C1
CMA
CNR1,CAMK2A
CNR1,CAMK2A,GAD2
CNR1,CAMK2A,GAD2,SLC17A6
CNR2
collagen genes
CPT1A
CRISPR
CSD
CSVD
CT
CVMS
CX3CR1
Cx43
CXCL10
DACT1, DAAM1, APOE
DACT1, DAAM1, KCNJ3
DACT1, DAAM1, KCNJ3, KLHDC4, SLC10A7, PPP4R2
DAM
DGAT1/GPX4/PLIN2
DLB
DNAJB1/DNMT1/FKBP5
DNAJC6
DNM1
DNMT1/DRD2/HSPA1A
doublecortin (DCX)
DPYD
DREADD
DS
E2F1, E2F2, E2F3, E2F7, E2F8
E2F1, E2F2, E2F3, E2F7, E2F8, G2/M phase genes
E4
EFNB1, EPHB4, TP53, TP63
EFNB1, EPHB4, TP53, TP63, SRC, ERK, AKT
EIF2S1, EIF2AK3/PERK, PPP1R15B, EIF2B
EPI
ER
EXT1
FBXL4, RSRC1
FBXO7
FCGRT
FERRO
filamin
FOXO1/G3BP1/HSPA1A
FOXO1/MCU/MIRO1
FOXO3/GJA1/MCU
FTD
FTLD
FXTAS
G3BP
G3BP1
Gabra1, Gabrg2
GABRA1, GABRG2
Gabra1, Gabrg2, Gabrb2
GAP43/GJA1/RAB27A
GAP43/HNRNPA2B1/MAP6
GAP43/MIRO1/PRKAA1
GBA
GBA1
GFAP
GJA1
GLP
GPR109A
GPR109A, MAPK1, MAPK14, MAPK8, MAPK9
GPR32
GPR37
GPX4
GRN
GWAS
HCN1
HD
HDAC3
HDAC4, NHE6
HDAC4, NHE6, LAMP2
HDAC4, NHE6, LRP1
HIF1A
histone H3
HK2
HK2/PLIN2/PPARGC1A
HMGCS2
Hmgcs2, Cd36, Cpt1a, Acat1
Hmgcs2, Oxct1
HNRNPA2B1/SETX/SRPK1
HNRNPA2B1/SETX/TARDBP
HOMER1A,GRIA1,GRIA2,GRIA3,GRIA4
HOXA5, miR-130a
HSP90AA1/LRP1/SNAP25
HSP90AA1/MAP6/SNAP25
HSV
IBA1
ID
IDH1, IDH2
IGHG1
IL10
IL-6
integrin-β1, tensin-1, YAP
IPCD signature genes
IRF1, NLRC5, CIITA
JUN, TNF
KCNJ3, APOE
All Replication Status
Single Study
Replicated
Partial Replication
Not Replicated
Search
All Types
animal_model (7)
cell_biology (8)
clinical (171)
computational (12)
exploratory (242)
falsification (27)
gene_expression (6)
genetic_association (16)
in-vitro (4)
in_vitro (2)
in-vivo (5)
in_vivo (8)
neuropathology (14)
validation (202)
Sort by:
Score
Feasibility
Novelty
Cost
Newest
cell_biology
0.50
Early disease phase characterized by remyelination response from oligodendrocyte precursor cells.
🧬 N/A
🏥 Alzheimer's disease
🔗 1 hyp
💰 N/A
⏱ N/A
✅ 0.00
✨ 0.00
cell_biology
0.50
Single nuclei multiomic profiling (transcriptomes, epigenomes, spatial coordinates) of 84 human donors spanning AD patho
🧬 N/A
🏥 Alzheimer's disease
🔗 1 hyp
💰 N/A
⏱ N/A
✅ 0.00
✨ 0.00
cell_biology
0.50
iPSC-derived AD model with optical electrophysiology enabled mechanistic investigation of spheroid formation, demonstrat
🧬 MTOR
🏥 Alzheimer's disease
🔗 1 hyp
💰 N/A
⏱ N/A
✅ 0.00
✨ 0.00
cell_biology
0.50
Released prosaposin (PSAP) was shown to induce interleukin-6 (IL-6) upregulation and secretion from oligodendrocytes via
🧬 IL-6
🏥 Parkinson's disease
🔗 1 hyp
💰 N/A
⏱ N/A
✅ 0.00
✨ 0.00
cell_biology
0.50
Temporal analysis of cell-type proportions revealed early reduction of Somatostatin-expressing neuronal subtypes and lat
🧬 SST|PVALB
🏥 Alzheimer's disease
🔗 1 hyp
💰 N/A
⏱ N/A
✅ 0.00
✨ 0.00
cell_biology
0.50
Multiomic single nucleus profiling mapped transcriptomes, epigenomes, and spatial coordinates of cell types in the middl
🧬 N/A
🏥 Alzheimer's disease
🔗 1 hyp
💰 N/A
⏱ N/A
✅ 0.00
✨ 0.00
cell_biology
0.50
Temporal analysis of cell-type proportions revealed early reduction of Somatostatin-expressing neuronal subtypes, late d
🧬 N/A
🏥 Alzheimer's disease
🔗 1 hyp
💰 N/A
⏱ N/A
✅ 0.00
✨ 0.00
cell_biology
0.50
Human iPSC-derived AD model with optical electrophysiology demonstrated that mTOR inhibition ameliorates spheroid pathol
🧬 MTOR
🏥 Alzheimer's disease
🔗 1 hyp
💰 N/A
⏱ N/A
✅ 0.00
✨ 0.00
Loading more experiments...
All 8 experiments loaded